Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)

NCT05776069 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Von Willebrand Diseases

Interventions

DRUG: VGA039
OTHER: Placebo
DRUG: VGA039

Sponsor

Vega Therapeutics, Inc